Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00833547 · ClinicalTrials.gov registry record · NA

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

A NA study of Schizophrenia, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
25
Enrollment target
1
Study location

NCT00833547 is a NA study of Schizophrenia that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00833547, a NA study of Schizophrenia, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target
1
Study location

Study Summary

This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture and sleep latency as measured by actigraphy and polysomnography and sleep-dependent motor skill learning.

Conditions Studied

Schizophrenia

Interventions

  • DRUG placebo
  • DRUG eszopiclone

Study Locations (1)

Massachusetts

  • Mass General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2006-09
Est. Completion 2012-09
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00833547

The ClinicalTrials.gov registry entry for NCT00833547 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00833547 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00833547 about?

NCT00833547 is a clinical study titled "Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia". This study will determine whether eszopiclone will normalize sleep patterns and restore sleep-dependent enhancement of motor skill learning in patients with schizophrenia. The investigators will compare subjects taking a placebo to those taking 3 mg of eszopiclone with regard to: sleep architecture ...

What is the current status of trial NCT00833547?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2006-09. Estimated completion is 2012-09.

What conditions does trial NCT00833547 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00833547?

The interventions under investigation include: placebo (DRUG), eszopiclone (DRUG).

Who is sponsoring clinical trial NCT00833547?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00833547 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.